STAT Launches Series Examining Alcohol-Related Deaths, Treatment Gaps and Policy Responses
STAT published an investigative series on May 12, 2026, detailing how alcohol kills more Americans than opioids, fentanyl, methamphetamines or heroin. Reporters Isabella Cueto and Lev Facher examined inconsistent screening, fragmented treatment and underused medications. The series draws on more than 100 expert interviews and highlights gaps persisting in the Trump administration.
news.sky.comSTAT published a new investigative series titled 'The Deadliest Drug' on May 12, 2026. Written by Isabella Cueto and Lev Facher, the series catalogs the nation's failure to address excessive alcohol use as a leading cause of disease, injury and death. Alcohol kills 178000 Americans each year.
It remains more deadly than opioids, fentanyl, methamphetamines or heroin, even as drinking rates have dipped to historic lows in those under 50. Screening for excessive drinking and related health problems is inconsistent and tends to flag only severe cases.
Many health care providers are uncomfortable pressing patients on their drinking levels, referring them to treatment, or prescribing medications known to help reduce or eliminate alcohol consumption.
U.S. relies disproportionately on individual willpower and on the ideology and practices of 12-step programs like Alcoholics Anonymous. Alcoholics Anonymous has helped millions quit alcohol, yet its sometimes dogmatic approach has failed many who reject its God-centric bent or wish to reduce rather than eliminate drinking.
The nation’s treatment infrastructure for excessive alcohol consumption remains fragmented. U.S. Most cases of alcohol use disorder are mild or moderate.
Even so, many Americans seeking treatment are forced to choose between labeling themselves “alcoholics” and never drinking again or forgoing treatment altogether. U.S. is facing a twin epidemic of alcohol use and metabolic disease.
More young Americans are dying from liver disease than ever before, a trend experts link to the combination of alcohol and poor diet amid ongoing crises of obesity, diabetes and cardiovascular disease. U.S. drink.
About 25% of pregnant women who drink report having more than four drinks in one occasion, according to STAT analysis of federal data. Experts worry that increasingly relaxed attitudes could drive a wave of neurodevelopmental issues estimated to be more common than autism. STAT conducted more than 100 interviews with experts.
Those experts told the news outlet that these alcohol-driven problems will continue to plague the country if left unchecked. The series finds that lawmakers, regulators and administration officials have let public health-focused proposals wither away.
Approaches such as higher state-level fees or updated labels could make a dent in alcohol abuse and its dangers, yet even in the age of Make American Healthy Again the Trump administration has kept alcohol risks outside the limelight.
This widespread denial pervades even the Trump administration, which has been more attuned to the burden of addiction than any in recent memory. if the administration continues to ignore the epidemic of problem drinking and addiction, it is unlikely to improve Americans’ health. “You can’t have MAHA without mental health and addiction,” Patrick Kennedy told STAT.
Key Facts
Potential Impact
- 01
Underutilization of medications and harm-reduction strategies may prolong reliance on willpower and AA for mild-to-moderate cases
- 02
Continued policy inaction on alcohol labeling, fees, and treatment access will sustain 178000 annual deaths and rising young liver disease mortality
- 03
Pregnant women and children exposed to alcohol remain vulnerable to falling through health system cracks, potentially increasing neurodevelopmental disorders
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…